期刊文献+

冠心病合并脑血管疾病的治疗进展 被引量:5

Progress in treatment of cerebrovascular diseases complicating coronary artery heart disease
下载PDF
导出
摘要 目前,心脑血管疾病是危及人类健康最常见的疾病之一。尽管冠心病与脑血管疾病具有共同的危险因素,但其治疗却不尽相同,二者同时发生时,病情常常会更严重,治疗也会更棘手。本文从冠心病合并缺血性卒中、出血性卒中或颅内动脉瘤的治疗现况方面进行综述。 Recently cardiovascular and cerebrovascular diseases have become one of the most common diseases seriously harmful to human health.Although coronary artery heart disease and cerebrovascular diseases share some risk factors,they are different to some extent in treatment.Importantly,concurrent coronary artery heart disease and cerebrovascular disease is usually more serious and the treatment is also much more challenging.This review paper examines the existing literature on the treatments of simultaneous coronary artery heart disease and ischemic or hemorrhagic stroke or intracranial aneurysms.
作者 杨升华 高峰 曹勇 郭彩霞 YANG Sheng-hua;GAO Feng;CAO Yong;GUO Cai-xia(Department of Cardiology,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China;Department of Neuro Intervention,Beijing Tiantan Hospital,Capital Medical University,Beijing100070,China;Department of Neurosurgery,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China)
出处 《中国医学前沿杂志(电子版)》 2019年第3期8-13,共6页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
基金 国家自然科学基金(81870265) 中国中青年临床研究基金项目(2017-CCA-VG-045)
关键词 冠心病 卒中 颅内动脉瘤 治疗 Coronary artery heart disease Stroke Intracranial aneurysms Treatment
  • 相关文献

参考文献5

二级参考文献104

  • 1Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 2Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282. 被引量:1
  • 3Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005. 被引量:1
  • 4Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442. 被引量:1
  • 5Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213. 被引量:1
  • 6Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7. 被引量:1
  • 7Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312. 被引量:1
  • 8Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617. 被引量:1
  • 9Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439. 被引量:1
  • 10Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032. 被引量:1

共引文献2218

同被引文献50

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部